| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
C4 Therapeutics, Inc. (CCCC) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. CCCC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 165.1K | $711.7K | - | |
| Other | 156.4K | $674.0K | - | |
| Dir | 146.5K | $631.6K | - | |
| Other | 105.0K | $452.5K | - | |
| Dir | 66.1K | $285.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2020 | Salter Malcolm83 | Director | Buy | 1,315 | $19.00 | $24,985.00 | +9.0% |